josh hardman (@josh__hardman) 's Twitter Profile
josh hardman

@josh__hardman

Covering all aspects of psychedelics at @Psyched_Alpha. Full of microplastics.

ID: 1344083599889469440

linkhttps://joshdidit.com/ calendar_today30-12-2020 00:51:26

2,2K Tweet

3,3K Takipçi

345 Takip Edilen

josh hardman (@josh__hardman) 's Twitter Profile Photo

"In this video, [Max Feinstein] visit[s] a research lab that is studying what happens to the brain under anesthesia, and how that might help people with PTSD." A great weekend watch... youtube.com/watch?v=dmp5dy…

josh hardman (@josh__hardman) 's Twitter Profile Photo

Big news! Still requires passage in the Senate and the President's autograph, but those close to the matter seem to think it's a shoo-in.

josh hardman (@josh__hardman) 's Twitter Profile Photo

Big news this morning! I spoke with people close to the companies to learn more about the deal, which values Beckley Psytech at around $370M. atai also retains right to walk away if Phase 2b data doesn't meet certain criteria. Race with GH Research still neck-and-neck.

Florian Brand (@flobrand) 's Twitter Profile Photo

As always very much worthwhile reading Harry Tracy's perspectives on recent developments in the CNS field, including his reflections on the upcoming Compass Pathways ' COMP360 and atai Life Sciences / Beckley Psytech's BPL-003 trial readouts. And couldn't agree more with him and

As always very much worthwhile reading <a href="/HarryNeuro/">Harry Tracy</a>'s perspectives on recent developments in the CNS field, including his reflections on the upcoming <a href="/COMPASSPathway/">Compass Pathways</a> ' COMP360 and <a href="/atai_life/">atai Life Sciences</a> / <a href="/BeckleyPsytech/">Beckley Psytech</a>'s  BPL-003 trial readouts. 

And couldn't agree more with him and
Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

Speaking at Prague Castle, Rick Doblin, Ph.D., of MAPS of MAPS presents on the potential of psychedelic therapies for war veterans. As part of his presentation, he shared our Psychedelic Drug Development Bullseye Chart, among other resources.

Speaking at Prague Castle, <a href="/RickDoblin/">Rick Doblin, Ph.D., of MAPS</a> of <a href="/MAPS/">MAPS</a> presents on the potential of psychedelic therapies for war veterans.

As part of his presentation, he shared our Psychedelic Drug Development Bullseye Chart, among other resources.
josh hardman (@josh__hardman) 's Twitter Profile Photo

“There’s far more people out there who have not had a positive experience — who have not had the therapeutic effect from ibogaine — than there are people who have,” [Alan K.] Davis said. washingtonpost.com/health/2025/06…

Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

Our Founder and Editor josh hardman hosted a panel on funding psychedelic research and access at The REAL Mental Health Summit today in London. Ft. Genevieve Jurvetson, Kabir Nath (Compass Pathways), Steve Jurvetson, and JLS Fund’s Lindsay Hoover.

Our Founder and Editor <a href="/Josh__Hardman/">josh hardman</a> hosted a panel on funding psychedelic research and access at The REAL Mental Health Summit today in London.

Ft. <a href="/gjurvetson/">Genevieve Jurvetson</a>, Kabir Nath (Compass Pathways), <a href="/FutureJurvetson/">Steve Jurvetson</a>, and <a href="/FundJls/">JLS Fund</a>’s Lindsay Hoover.
Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

Australia’s largest health insurance company, Medibank, has carved out AUD $10M (USD $6.5M) to fund a psychedelic therapy pilot program for its eligible members, who won’t pay a penny in out-of-pocket costs. More: psychedelicalpha.com/news/australia…

Australia’s largest health insurance company, Medibank, has carved out AUD $10M (USD $6.5M) to fund a psychedelic therapy pilot program for its eligible members, who won’t pay a penny in out-of-pocket costs.

More: psychedelicalpha.com/news/australia…